OpenAI says it will not pursue an IPO in 2026

Published Saturday, September 12, 2026 · 4:06 PM EDT

OpenAI CEO Sam Altman confirmed that the company will not go public in 2026, according to Fortune. Altman cited the safety situation as making an offering inadvisable at present. The decision delays a potential public listing that had been widely anticipated.

Sources

Techmeme Mashable

In this story

OpenAI Sam Altman

Published by Tech & Business, a media brand covering technology and business. This story was sourced from Techmeme, Mashable and reviewed by the T&B editorial agent team.

Back to Newswire

Keep reading

Full wire

Capital AI

Disruptive announces $10 billion fund for late-stage AI and defense bets

Disruptive announced a $10 billion fund Tuesday to back at least 10 late-stage companies, with individual investments of up to $1 billion, TechCrunch reported. The Dallas investment firm is targeting capital-intensive AI and defen...

Products Capital

Re:Build raises $2.1 billion to expand manufacturing and industrial startups

Re:Build has raised $2.1 billion in a round led by General Catalyst and JPMorganChase's Strategic Investment Group. The Massachusetts manufacturing accelerator said Tuesday that it will use the money to expand its capacity to manu...

Capital

Former Benchmark investors raise $1.252 billion for Diffusion ONE

Former Benchmark investors Victor Lazarte and Kris Fredrickson have raised $1.252 billion for their debut AI fund, Diffusion ONE, TechCrunch reported from SEC filings. The total exceeds the $800 million target Forbes reported in M...

Infrastructure Products

ASM raises 2027 revenue forecast to more than €5.7B

ASM International raised its 2027 revenue forecast to more than €5.7B from above €4.6B forecast in July, as memory and advanced AI chipmakers expand production. The chip-equipment maker said the revised outlook would reach its 203...

Capital AI

Anthropic acquires Mithril Medicine and starts its own drug research

Anthropic says it has acquired Mithril Medicine, a one-person company developing treatments for two rare forms of muscular dystrophy, and begun running drug discovery programs itself. Founder Cody Tranbarger is continuing the rese...

Capital AI

Avante raises $30M Series A for employee benefits platform

Avante raised a $30M Series A for its AI platform that helps companies manage employee healthcare and other benefits, GeekWire reported. The financing follows a $10M seed round in 2024 and adds capital to the employee benefits sof...